BioSpace News Archive

Unified Physician Management introducing AI-powered, voice-enabled tool across a network of over 1,500 women’s health providers to maximize clinician time with patients

Kareo Further Strengthens Board of Directors with Appointment of Scott Maxwell and David Cozzens

TrialResults.com helps lead the way in assisting clinical trial sponsors to #BeTransparent

On Tuesday, June 18, 2019, Cardiovascular Systems’ Chairman, President and Chief Executive Officer, Scott Ward, will present at the Raymond James Life Sciences & MedTech Conference at 9:45 a.m. Eastern Time.

Thommen Medical USA, a leading Swiss manufacturer of dental implant solutions, announces that it has a new leadership team.

Innovia Medical has partnered with Medical Device Resource Corporation.

RMAT designation follows positive Phase 2 proof-of-concept data published in the Journal of Clinical Oncology (JCO) for Viralym-M, an allogeneic, off-the-shelf multi-virus specific T-cell therapy

KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS ≥1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 Expression

CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company at the Three Part Advisors 2019 East Coast IDEAS Investor Conference on Thursday, June 13, 2019 in Boston, MA. Dr. Chan will also meet with investors in 1x1 meetings throughout the day.

Kraig Biocraft Laboratories, Inc. announces that a senior member of its leadership team is travelling to Vietnam to oversee operations at the Company’s subsidiary Prodigy Textiles Ltd., construction at the Company’s new facility, and to coordinate the transfer of silkworms from the temporary facility into their permanent home.